DCF — GERALD CHAMPION REGIONAL MEDICAL CTR
Enterprise Value: $-445.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-445.2M
Enterprise Value
$-140.0M
PV of Cash Flows
$-305.2M
PV of Terminal Value
$-491.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $253.3M | $-28.2M | -11.0% | $-38.9M | $-35.4M |
| Year 2 | $260.9M | $-26.4M | -10.0% | $-37.5M | $-31.0M |
| Year 3 | $268.8M | $-24.5M | -9.0% | $-35.9M | $-27.0M |
| Year 4 | $276.8M | $-23.9M | -9.0% | $-35.6M | $-24.3M |
| Year 5 | $285.1M | $-23.9M | -8.0% | $-36.0M | $-22.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-445.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$245.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11630342673084065
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5